Rheumatoid arthritis is a condition in which a person suffers from a faulty immune system that continuously attacks tissues of the body. The tissues that are frequently attacked are usually those that are more or less always mobile as well as those that bear weight (rare) as well as those tissues that are found in the joints. Many companies that produce pain relievers and other medications related to arthritis seek rheumatoid arthritis treatment options which are new that may be different from what is currently in the market. The reason for the quest for rheumatoid arthritis new treatment is based mainly on the fact that the drugs currently on the market have undesirable side effects which can severely damage vital organs as well as contribute to heart disease and digestive problems.

New Treatments

Every once in a while, rheumatoid arthritis new treatment studies and proposals crop up but these need to undergo rigorous studies and research before the government can give the go signal to manufacture or produce these. Usually the rheumatoid arthritis new treatment is derived from chemicals which make these just as effective and as dangerous as the drugs currently on the market as of the moment. Rheumatoid arthritis new treatment drugs and medications usually strive to control and manage the immune system as well as reduce the symptoms of the condition. The governing body that regulates rheumatoid arthritis new treatments usually demand several years of research and study before allowing mass and commercial production of the drug or treatment. This helps to avoid unnecessary harm and injury to test subjects, whether they are human or not. Damage to vital organs and the digestive system is the usually result of taking arthritic medication too much and too long.

Remicade

Remicade is a rheumatoid arthritis new treatment drug that can supposedly inhibit the protein that contributes to the inflammation of the joints. One should note that the difference of this rheumatoid arthritis new treatment is that it blocks the naturally occurring protein from ever occurring thus stopping the progression of this condition. The implications of being able to stop the progress of rheumatoid arthritis mean that a person can actually forget about ever having the condition in the first place. This rheumatoid arthritis new treatment is currently in the market and was actually long before the turn of the millennium. It was initially approved by the Food and Drug Administration of the United States of America in the year 2002 and is being manufactured up to now.